RRR-ALPHA-TOCOPHEROL CONCENTRATE
Nonalcoholic Steatohepatitis (NASH)
Lipocine Inc.Small moleculePhase 2Dormant
B
57/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 42/ 100
- Competitive Position
- 95/ 100
Competitive context
7 Active assets in the Nonalcoholic Steatohepatitis (NASH) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
URSODEOXYCHOLIC ACID Kafrelsheikh University | Phase 4 | BBB |
zsp1601 Guangdong Raynovent Biotech Co., Ltd | Phase 2 | BB |
hec96719 Sunshine Lake Pharma Co., Ltd. | Phase 2 | BB |
Cilofexor Gilead Sciences | Phase 2 | B |
Arachidyl amido cholanoic acid Galmed Research and Development, Ltd. | Phase 3 | B |
View all 17 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →